drugset / Trial / NCT02071160

Melatonin for Neuroprotection Following Perinatal Asphyxia

NCT02071160

Phase 1/2 Completed 45 enrolled Tanta University
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to examine the effect of combining melatonin to whole body cooling on the brain injury and outcome of neonates following perinatal asphyxia.

Timeline

Start
2012-01
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 10 mg/kg Other

Indications